Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, finishing (PDF) g...

Daiichi pays for Merck $170M to create lung cancer cells T-cell engager contract

.Merck &amp Co. has actually rapidly redeemed a few of the expenses of its own Javelin Rehabs acquis...

BioMarin standstills preclinical genetics treatment for heart condition

.After BioMarin administered a springtime clean of its own pipe in April, the provider has determine...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks handle

.Major Pharmas stay caught to the suggestion of molecular glue degraders. The most recent company to...

Life science credit scores agency introduces along with $600M

.A brand new international life science credit report organization, referred to as Symbiotic Funding...

BMS trenches TIGIT, walking away from $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing yet another huge wager coming from the Caforio age, canceling a packa...

Nuvation standstills BET prevention after thinking about phase 1 record

.After having a look at phase 1 data, Nuvation Biography has made a decision to stop deal with its s...

' Professional intuitiveness' led FDA experts to support Zevra's rare disease med

.Zevra Therapies' unusual disease medication seems to be to become on the road to permission this au...

Pfizer takes $230M struck after axing stopped working DMD gene treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failure has gone a $230 million ...

AC Immune sees 'site' prospective in Alzheimer's drug information

.After much more than 20 years of focus on neurodegenerative conditions, Swiss biotech AC Immune ins...